Stryker Corporation manufactures and distributes medical devices and technologies across surgical, neurotechnology, and orthopedic applications. The company operates in approximately 61 countries through company-owned subsidiaries and branches as well as third-party dealers and distributors, serving doctors, hospitals, and healthcare facilities globally.
The MedSurg and Neurotechnology segment encompasses surgical equipment, patient safety technologies, navigation and endoscopic systems, patient handling devices, and emergency medical equipment. This segment also includes minimally invasive products for acute ischemic and hemorrhagic stroke treatment, venous thromboembolism management, and traditional brain and skull-based surgical procedures, alongside orthobiologic and biosurgery products such as synthetic bone grafts and vertebral augmentation systems. The Orthopaedics segment focuses on implants for total joint replacements in the hip, knee, shoulder, and ankle, as well as trauma and extremities surgeries. The segment also includes Mako Shoulder, an addition to the company's smart robotics platform.
Stryker employs 56,000 full-time employees and operates as a publicly traded company on the NYSE with a market capitalization of $142.6 billion. Founded in 1941 and incorporated in Michigan, the company maintains its headquarters in Portage, Michigan.
Fiscal years are as reported by the company and may not align with the calendar year. For example, Apple's FY 2024 ends in September 2024.
| Fiscal Year | EPS Diluted | EPS Basic | YoY | |
|---|---|---|---|---|
| 2025 | $2.20 | $2.21 | +56.0% | |
| 2024 | $1.41 | $1.43 | -52.7% | |
| 2023 | $2.98 | $3.01 | +102.7% | |
| 2022 | $1.47 | $1.48 | -15.0% | |
| 2021 | $1.73 | $1.75 | +16.1% | |
| 2020 | $1.49 | $1.51 | -21.6% | |
| 2019 | $1.90 | $1.94 | -65.1% | |
| 2018 | $5.44 | $5.52 | +924.2% | |
| 2017 | $-0.66 | $-0.66 | -149.3% | |
| 2016 | $1.34 | $1.36 | -2.9% | |
| 2015 | $1.38 | $1.39 | +106.0% | |
| 2014 | $0.67 | $0.68 | -33.7% | |
| 2013 | $1.01 | $1.02 | +42.3% | |
| 2012 | $0.71 | $0.71 | -32.4% | |
| 2011 | $1.05 | $1.05 | +41.9% | |
| 2010 | $0.74 | $0.75 | -73.3% | |
| 2009 | $2.77 | $2.79 | — |
| Report Date | Filed | Accession Number | |
|---|---|---|---|
| 2025-12-31 | 2026-02-11 | 0000310764-26-000010 | SEC ↗ |
| 2024-12-31 | 2025-02-12 | 0000310764-25-000023 | SEC ↗ |
| 2023-12-31 | 2024-02-14 | 0000310764-24-000024 | SEC ↗ |
| 2022-12-31 | 2023-02-10 | 0000310764-23-000017 | SEC ↗ |
| 2021-12-31 | 2022-02-11 | 0000310764-22-000028 | SEC ↗ |
| 2020-12-31 | 2021-02-11 | 0000310764-21-000027 | SEC ↗ |
| 2019-12-31 | 2020-02-06 | 0000310764-20-000014 | SEC ↗ |
| 2018-12-31 | 2019-02-07 | 0000310764-19-000014 | SEC ↗ |
| 2017-12-31 | 2018-02-08 | 0000310764-18-000031 | SEC ↗ |
| 2016-12-31 | 2017-02-09 | 0000310764-17-000034 | SEC ↗ |